sezione lavoro; sentenza 7 novembre 1991, n. 11872; Pres. Menichino, Est. Nuovo, P.M. Martinelli (concl. conf.); Regione Campania (Avv. Cioffi) c. Ente nazionale di previdenza ed assistenza medici (Avv. Tedeschi) e Rizzo; Min. tesoro c. Ente nazionale di previdenza ed assistenza medici ed altri; Rizzo (Avv. Avella) c. Min. tesoro, Regione Campania ed altri. Cassa Trib. Napoli 14 giugno 1989

Autor: Caruso, Giuseppe

Publikováno v: Il Foro Italiano, 1992 Jan 01. 115, 3049/3050-3057/3058.

Externí odkaz: https://www.jstor.org/stable/23187025

Sezione I civile; sentenza 11 ottobre 1972, n. 2999; Pres. Stella Richter P., Est. Spadaro, P.M. Di Majo (concl. conf.); Cassa per il Mezzogiorno (Avv. dello Stato Avella) c. Lazzaro (Avv. Andrioli, Chiozza, Greco)

Publikováno v: Il Foro Italiano, 1973 Feb 01. 96(2), 397/398-403/404.

Externí odkaz: https://www.jstor.org/stable/23161864

Sezione I civile; sentenza 8 luglio 1974, n. 1985; Pres. Giannattasio P., Est. V. Novelli, P. M. De Marco F. (concl. conf.); Min. finanze (Avv. dello Stato Avella) c. Priotti (Avv. Bongianni)

Publikováno v: Il Foro Italiano, 1974 Jan 01. 97, 2641/2642-2643/2644.

Externí odkaz: https://www.jstor.org/stable/23165911

Udienza 7 settembre 1891: Pres. Lamanna P. P., Est. Scandurra; Giordano (Avv. Gramignani, Avella) c. Ingria (Avv. Accascina, Mazi)

Publikováno v: Il Foro Italiano, 1892 Jan 01. 17, 287/288-289/290.

Externí odkaz: https://www.jstor.org/stable/23100578

Brief Report: Osimertinib Plus Capmatinib for Patients With MET-Altered EGFR-Mutant NSCLC Following Progression on Front Line Therapy.

Autor: Elghawy O; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Barsouk A; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Reed-Guy L; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Stalker M; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Sussman J; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Robinson K; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Kosteva J; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Singh A; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Cohen RB; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Langer C; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Ciunci C; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., D'Avella C; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Sun L; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Marmarelis ME; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Aggarwal C; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.. Electronic address: Charu.Aggarwal@pennmedicine.upenn.edu.

Publikováno v: Clinical lung cancer [Clin Lung Cancer] 2024 Dec 13. Date of Electronic Publication: 2024 Dec 13.